Immunology publishes papers describing original findings in all areas of cellular and molecular immunology. High-quality original articles describing mechanistic insights into fundamental aspects of the immune system are welcome. Topics of interest to the journal include: immune cell development, cancer immunology, systems immunology/omics and informatics, inflammation, immunometabolism, immunology of infection, microbiota and immunity, mucosal immunology, and neuroimmunology.

EDITOR-IN-CHIEF
Professor Simon Milling
University of Glasgow, UK
Keywords: Immunology of the Intestine, Dendritic Cells, Models of Infection, Inflammatory Disease
 
 
Simon Milling is an immunologist working on the immunology of the intestine. His lab focusses on the biology of antigen presenting cells in the intestine, and on how these cells respond to infectious or inflammatory stimuli. He was trained at Imperial College, London, and worked as a postdoctoral researcher in Philadelphia and in Oxford. He moved to Glasgow as a Lecturer in 2007 and became a Full Professor in 2017.
ASSOCIATE EDITORS
 
Dr Awen Gallimore
Cardiff University, UK
Keywords: Cancer, Cancer-Antigens,  Regulatory T cells, Immune-modulation
 
Awen Gallimore is a Professor at the Division of Infection and Immunity, Cardiff University. She gained a DPhil in Professor Andrew McMichael's laboratory in Oxford, studying the anti-viral role of cytotoxic T cells in SIV infection, subsequently moving to Professor Rolf Zinkernagel's laboratory to study the correlates of anti-viral immunity. Her current focus is on the regulation of anti-tumour immunity, with a particular focus on regulatory T cells (Treg). The group takes basic research using animal models of cancer through to testing novel immunotherapies in patients with colorectal cancer (CRC). In the case of CRC, the group has found that Tregs are associated with disease progression and a paucity of T cell responses to tumour-associated antigens. Modulation of Treg numbers restores these immune responses, possibly leading to control of disease progression. In the case of mouse models, the group has found that Treg impact on the tumour vasculature and that modulating Treg numbers/activity results in alterations to the vasculature that serve to increase the frequency of tumour-infiltrating T cells and improve control of tumour growth.
 
Dr Florent Ginhoux
Singapore Immunology Network (SIgN), A*STAR, Singapore
Keywords: Ontogeny, Development, Differentiation, Dendritic Cell, Monocyte, Macrophage
 
Doctor Florent Ginhoux is a senior Principal Investigator at the Singapore Immunology Network (SIgN), A*STAR. He is also an Adjunct Visiting Associate Professor in the Shanghai Immunology Institute, Jiao Tong University, China. He received his PhD in 2004 from the University Pierre et Marie CURIE, Paris VI. He is a EMBO Young Investigator (YIP) since 2013 and is a Web of Science Highly Cited Researcher since 2016. Both his laboratories are focusing on the ontogeny and differentiation of macrophages and dendritic cells (DCs).
 
Professor Kathleen McCoy
University of Calgary, Canada
Keywords: Microbiome, mucosal immunology, innate immunity, B cells, allergy
 
Kathy McCoy is a Professor in the Department of Pharmacology and Physiology in the Cumming School of Medicine at the University of Calgary, Canada. Her group studies the dynamic interplay between the gut microbiota and the innate and adaptive immune systems. She obtained her PhD in Immunology from the Malaghan Institute of Medical Research, Otago University, Wellington, New Zealand and held positions in Zürich, Hamilton and Bern before moving to Calgary in 2016. Using germ-free and gnotobiotic mouse models her research group aims to understand how exposure to intestinal microbes, particularly during early life, educates and regulates the mucosal and systemic immune systems and how this impacts on susceptibility to diseases, such as allergy and autoimmunity.
 
Professor Francisco J. Quintana
Harvard Medical School, USA
Keywords: Immune regulation, T cells, dendritic cells, astrocytes, autoimmunity
 
Francisco J. Quintana is an Associate Professor of Neurology at the Center for Neurologic Diseases at Brigham and Women’s Hospital, Harvard Medical School. He received his PhD from the Weizmann Institute of Science and moved to Boston in 2005. Francisco’s main research focus is on signaling pathways that regulate the immune response, with a particular emphasis on their relevance for the pathogenesis and treatment of autoimmune disorders.
 
 
Editorial Board
A Akbar, University College London, United Kingdom
S Akira, Osaka University, Japan
P Askenase, Yale Medical School, United States
A Astier, University of Edinburgh, United Kingdom
M Bonneville, Inserm, France
C G Brooks, University of Newcastle, United Kingdom
M Carrington, Ragon Institute of MGH, MIT & Harvard, United States
T Clarke, Imperial College London, United Kingdom
D Cole, Cardiff University, United Kingdom
D M Davis, Imperial College, United Kingdom
S Davis, University of Manchester, United Kingdom
J Davoust, Inserm, France
M Dustin, University of Oxford, United Kingdom
T Elliott, University of Southampton, United Kingdom
T Evans, University of Glasgow, United Kingdom
A Hayday, Kings College London, United Kingdom
Y He, Duke University, United States
H Hengartner, University Hospital of Zurich, Switzerland
M Hepworth, University of Manchester, United Kingdom
S Jameson, University of Minnesota, USA
S Koyasu, Keio University, Japan
A MacDonald, University of Edinburgh, United Kingdom
G Macpherson, University of Oxford, United Kingdom
F Marelli-Berg, Imperial College, United Kingdom
C Mauri, University College London, United Kingdom
R Nibbs, University of Glasgow, United Kingdom
A O'Garra, National Institute Medical Research, United Kingdom
S J Powis, University of St Andrews, United Kingdom
F Powrie, Sir William Dunn School of Pathology, United Kingdom
D Price, Cardiff University, United Kingdom
C Rudd, Imperial College, United Kingdom
D M Sansom, University of Birmingham, United Kingdom
J Savill, University of Edinburgh, United Kingdom
D W Scott, Uniformed Services University of Health Sciences, USA
B Seddon, MRC National Institute for Medical Research, United Kingdom
B Sun, Shanghai, China
A R Thomsen, University of Copenhagen, Denmark
S Todryk, Northumbria University, United Kingdom
E Vivier, Centre d'Immunologie de Marseille-Luminy, France
F S Wang, Research Center for Biological Therapy, Beijing
H Wang, Shanghai Institute for Biological Sciences, Shanghai
C T Weaver, University of Alabama at Birmingham, United States
D Withers, University of Birmingham, United Kingdom
D Xu, University of Glasgow, United Kingdom
Immunology Editorial Office
The British Society for Immunology
34 Red Lion Square
London
WC1R 2SG
United Kingdom
Tel.: 44 (0)20 3019 5901
Fax: 44 (0)20 3019 5902
All manuscripts submitted to Immunology are peer-reviewed by two independent referees and also assessed by an editor prior to publication. Referees complete a standard evaluation form, as well as providing comments for the editors and authors, ensuring that the quality of manuscripts published in the Journal is maintained to a consistently high standard. Keywords aid in the selection of referees with appropriate expertise for each manuscript submitted.
The Journal is a member of the Committee on Publication Ethics (COPE) and authors submitting manuscripts to the journal are recommended to read the Guidelines on Good Publication Practice.
The Journal is also a member of the World Association of Medical Editors.